Scilex (SCLX) News Today $0.56 0.00 (-0.83%) (As of 01:20 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Scilex Holding Plans Merger to Boost Semnur ValueNovember 6, 2024 | markets.businessinsider.comSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to the Previously Announced Proposed Business Combination Between Semnur and DenaliNovember 6, 2024 | globenewswire.comPleasing Signs As A Number Of Insiders Buy Scilex Holding StockOctober 30, 2024 | finance.yahoo.comScilex announces successful end of Phase II meeting with FDAOctober 30, 2024 | markets.businessinsider.comScilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4%, a Next-Generation, Triple-Strength Formulation of ZTlido, for the Treatment of Chronic Neck Pain Associated with October 30, 2024 | globenewswire.comJaisim Shah Purchases 32,000 Shares of Scilex Holding (NASDAQ:SCLX) StockOctober 30, 2024 | insidertrades.comJaisim Shah Acquires 32,000 Shares of Scilex Holding (NASDAQ:SCLX) StockScilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah purchased 32,000 shares of the company's stock in a transaction dated Tuesday, October 29th. The stock was purchased at an average cost of $0.99 per share, with a total value of $31,680.00. Following the purchase, the insider now owns 109,333 shares in the company, valued at approximately $108,239.67. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.October 29, 2024 | marketbeat.comScilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common StockOctober 29, 2024 | globenewswire.comScilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned SubsidiaryOctober 28, 2024 | globenewswire.comWhat is HC Wainwright's Forecast for Scilex Q3 Earnings?Scilex Holding (NASDAQ:SCLX - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Scilex in a report released on Monday, October 21st. HC Wainwright analyst R. Selvaraju expects that the company will post earnings of ($0October 23, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "buy" rating and set a $7.00 price target on shares of Scilex in a report on Monday.October 21, 2024 | marketbeat.comScilex Holding (NASDAQ:SCLX) Director Yue Alexander Wu Acquires 20,000 SharesOctober 21, 2024 | insidertrades.comInsider Buying: Scilex Holding (NASDAQ:SCLX) Insider Acquires 30,000 Shares of StockOctober 18, 2024 | insidertrades.comScilex Holding (NASDAQ:SCLX) Insider Buys $29,700.00 in StockScilex Holding (NASDAQ:SCLX - Get Free Report) insider Jaisim Shah bought 30,000 shares of the stock in a transaction on Wednesday, October 16th. The stock was acquired at an average price of $0.99 per share, with a total value of $29,700.00. Following the completion of the acquisition, the insider now owns 77,333 shares of the company's stock, valued at $76,559.67. This represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.October 17, 2024 | marketbeat.comHolding Company Shares Rally Following Board Of Directors CommentaryOctober 16, 2024 | theglobeandmail.comScilex Holding To Explore Ways To Maximize Value Scilex Pharma.October 16, 2024 | markets.businessinsider.comScilex (NASDAQ:SCLX) Now Covered by Analysts at Alliance Global PartnersAlliance Global Partners began coverage on shares of Scilex in a research report on Wednesday. They issued a "buy" rating and a $14.00 price target on the stock.October 16, 2024 | marketbeat.comSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 BillionOctober 16, 2024 | globenewswire.comSCLX Grows Sales and Improves FinancesOctober 11, 2024 | msn.comScilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024October 8, 2024 | globenewswire.comScilex Holding Company Announces Closing of a $50 Million Registered Convertible FinancingOctober 8, 2024 | globenewswire.comOramed Pharmaceuticals Announces Restructuring of Scilex Holding Company DebtOctober 7, 2024 | finance.yahoo.comScilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial ProfileOctober 7, 2024 | globenewswire.comScilex Holding (NASDAQ:SCLX) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comArmistice Capital LLC Invests $23.06 Million in Scilex Holding (NASDAQ:SCLX)Armistice Capital LLC acquired a new stake in Scilex Holding (NASDAQ:SCLX - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 11,950,000 shares of the company's stock, valued at approximately $23,064,000. Armistice Capital LLC ownSeptember 26, 2024 | marketbeat.comScilex Holding Company Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®)September 12, 2024 | markets.businessinsider.comPrivate companies account for 46% of Scilex Holding Company's (NASDAQ:SCLX) ownership, while institutions account for 22%September 12, 2024 | finance.yahoo.comScilex Holding Company to Present at the 26th Annual H.C. Wainwright Global Investment ConferenceSeptember 10, 2024 | markets.businessinsider.comSCLX Makes Move to Boost Shareholder ValueSeptember 4, 2024 | msn.comSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 BillionSeptember 3, 2024 | globenewswire.comScilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024August 30, 2024 | globenewswire.comScilex Announces FDA Approval Of SNDA For Label Updates To GloperbaAugust 30, 2024 | markets.businessinsider.comScilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® LabelAugust 29, 2024 | globenewswire.comScilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute PainAugust 21, 2024 | globenewswire.comQ3 2024 EPS Estimates for Scilex Holding Reduced by Zacks Small Cap (NASDAQ:SCLX)Scilex Holding (NASDAQ:SCLX - Free Report) - Equities researchers at Zacks Small Cap reduced their Q3 2024 earnings per share (EPS) estimates for shares of Scilex in a note issued to investors on Wednesday, August 14th. Zacks Small Cap analyst B. Sorensen now forecasts that the company will postAugust 19, 2024 | marketbeat.comScilex (NASDAQ:SCLX) Shares Down 0.8% Scilex (NASDAQ:SCLX) Stock Price Down 0.8%August 17, 2024 | marketbeat.comSCLX: Sales AccelerateAugust 15, 2024 | msn.comSCLX Stock Earnings: Scilex Holding Misses EPS, Beats Revenue for Q2 2024August 13, 2024 | investorplace.comScilex Holding Company Enters into Master Distributor Agreement Among CH Trading Group and Devart Middle East for the Distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South AfricaAugust 9, 2024 | globenewswire.comScilex (NASDAQ:SCLX) Shares Down 0.6% Scilex (NASDAQ:SCLX) Stock Price Down 0.6%July 26, 2024 | marketbeat.comScilex Holding Company Announces Publication of Its Inaugural Sustainability ReportJuly 24, 2024 | globenewswire.comNon-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ DebutJuly 3, 2024 | benzinga.comSemnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business CombinationJuly 2, 2024 | globenewswire.comScilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New YorkJuly 2, 2024 | globenewswire.comScilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.June 20, 2024 | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Scilex (NASDAQ:SCLX)HC Wainwright reaffirmed a "buy" rating and set a $7.00 target price on shares of Scilex in a research note on Monday.June 17, 2024 | marketbeat.comScilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)June 14, 2024 | globenewswire.comScilex (NASDAQ:SCLX) Coverage Initiated by Analysts at Rodman & RenshawRodman & Renshaw assumed coverage on shares of Scilex in a research note on Thursday. They issued a "buy" rating and a $13.00 target price for the company.June 13, 2024 | marketbeat.comScilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio CompaniesJune 11, 2024 | globenewswire.comScilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®June 11, 2024 | globenewswire.com Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide SCLX Media Mentions By Week SCLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCLX News Sentiment▼0.800.47▲Average Medical News Sentiment SCLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCLX Articles This Week▼02▲SCLX Articles Average Week Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MKTW News AQST News CGC News TKNO News TNGX News AKBA News LRMR News KALV News VERV News VALN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCLX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
